MPM BioVentures 2014 reports Entrada Therapeutics share disposal worth $1.89 million
TRDA•MPM BioVentures 2014 reports share sales in Entrada Therapeutics
MPM BioVentures 2014 reported sales of 259,837 Entrada Therapeutics common shares from Sep. 4-9.
Weighted-average sale prices were $7.11, $7.41, and $7.13.
Indirect beneficial ownership fell to 3,885,115 shares following the latest sale.
